Repurposing of natural products for spinocerebellar ataxia type 3 using integrated network pharmacology and in silico approaches. [PDF]
Roney M +5 more
europepmc +1 more source
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies. [PDF]
Silva A +28 more
europepmc +1 more source
Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3. [PDF]
Chen CP +6 more
europepmc +1 more source
Early transcriptomic perturbations highlight the spinal cord as a key pathogenic region in spinocerebellar ataxia type 3. [PDF]
Emerson J +5 more
europepmc +1 more source
Investigation of the large-scale white-matter functional networks in spinocerebellar ataxia type 3. [PDF]
Tang J +9 more
europepmc +1 more source
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort. [PDF]
Silva P +25 more
europepmc +1 more source
Familial spinocerebellar ataxia type 3: A case report of multi-generational presentation. [PDF]
Wang J +7 more
europepmc +1 more source
Pediatric-onset spinocerebellar ataxia type 3 with dual <i>ATXN3</i> and <i>HTT</i> gene mutations: a case report and literature-informed hypothesis. [PDF]
Wang D +7 more
europepmc +1 more source
Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene. [PDF]
Rybarikova M +5 more
europepmc +1 more source

